| AINS | anti-inflammatory nonsteroidal |
|---|---|
| NOSAC | nonsteroidal anti-inflammatory compound |
| NSAI | nonsteroidal anti-inflammatory [drug] |
| NSAIA | nonsteroidal anti-inflammatory agent |
| NSAID | nonsteroidal anti-inflammatory drug |
| non-steroidal oestrogens | <pharmacology> Non-steroidal compounds with oestrogenic activity. (12 Dec 1998) |
|---|
| oestrogens | A class of sex hormones associated with the development and maintenance of secondary female sex characteristics and control of the cyclical changes in the reproductive cycle. They are also required for pregnancy maintenance and have an anabolic effect on protein metabolism and water retention. (12 Dec 1998) |
|---|---|
| oestrogens, catechol | 2- or 4-hydroxyoestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an oestrogenic action or interaction with the catecholaminergic system. (12 Dec 1998) |
| oestrogens, conjugated | An amorphous preparation containing water-soluble, conjugated forms of mixed oestrogens obtained from urine of pregnant mares. The principal oestrogen present is sodium estrone sulfate. The total oestrogenic potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. (12 Dec 1998) |
| oestrogens, synthetic | Compounds obtained by chemical synthesis which possess oestrogenic activity, but differ in structure from naturally occurring oestrogens. (12 Dec 1998) |
| esterified oestrogens | A mixture of the sodium salts of sulfate esters of oestrogenic substances; used for oral oestrogen therapy. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|